Study to Assess the Efficacy of Rina-S Compared to Treatment of Investigator's Choice in Participants With Platinum Resistant Ovarian Cancer (RAINFOL-02)
- GynOnco Group Team
- Aug 16
- 1 min read
STUDY ID: NCT06619236
STATUS: Enrolling
CONDITION: Ovarian Cancer
SPONSOR: Genmab
FOR MORE INFORMATION VISIT: https://clinicaltrials.gov/study/NCT06619236